Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Primary small cell carcinoma of the breast: a case report

Authors: Iman Abou Dalle, Jaber Abbas, Fouad Boulos, Ziad Salem, Hazem I. Assi

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Neuroendocrine breast cancer is a rare entity that was defined in 2003 by the World Health Organization as a separate breast cancer subtype. The diagnosis of neuroendocrine breast cancer requires the presence of neuroendocrine features in at least 50% of malignant cells, the exclusion of non-mammary primary tumors, as well as the presence of an in situ component in breast histology. The treatment and prognosis of neuroendocrine breast cancer are still not well established. Small cell carcinoma of the breast is a subtype of neuroendocrine cancer, resembling small cell carcinoma of the lung. It has a very poor prognosis and warrants treatment with platinum-based chemotherapy.

Case presentation

We herein report the case of a 47-year-old white woman with a left breast mass that was found to be an early-stage, high-grade small cell carcinoma of the breast. Positron emission tomography-computed tomography imaging excluded any other primary disease. Our patient underwent a left total mastectomy with sentinel lymph node biopsy and received cisplatin-based adjuvant chemotherapy. Our patient remains free of disease to date.

Conclusions

This case report sheds light on a rarely described disease and provides a comprehensive approach to diagnosis and management. Neuroendocrine carcinoma of the breast is a well-defined histologic subtype of breast cancer. Small cell carcinoma of the breast is a rare subtype of neuroendocrine breast cancer. Due to the rarity of this entity, prognosis has still not been well established, and treatment has not been standardized, cisplatin-based treatment has been used in this case similar to small cell carcinoma of the lung.
Literature
1.
go back to reference López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez J. Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep. 2008;20:1369–74.PubMed López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez J. Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep. 2008;20:1369–74.PubMed
2.
go back to reference Zhu Y, Li Q, Gao J, He Z, Sun R, Shen G, et al. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy. Breast J. 2013;19:382–7.CrossRefPubMed Zhu Y, Li Q, Gao J, He Z, Sun R, Shen G, et al. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy. Breast J. 2013;19:382–7.CrossRefPubMed
3.
go back to reference Tan PH, Schnitt SJ, van de Vijver MJ, Ellis IO, Lakhani SR. Papillary and neuroendocrine breast lesions: the WHO stance. Histopathology. 2015;66:761–70.CrossRefPubMed Tan PH, Schnitt SJ, van de Vijver MJ, Ellis IO, Lakhani SR. Papillary and neuroendocrine breast lesions: the WHO stance. Histopathology. 2015;66:761–70.CrossRefPubMed
4.
go back to reference Wachter DL, Hartmann A, Beckmann MW, Fasching PA, Hein A, Bayer CM, et al. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma. Biomed Res Int. 2014;2014:408–59.CrossRef Wachter DL, Hartmann A, Beckmann MW, Fasching PA, Hein A, Bayer CM, et al. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma. Biomed Res Int. 2014;2014:408–59.CrossRef
5.
go back to reference Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 2002;40:215–22.CrossRefPubMed Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 2002;40:215–22.CrossRefPubMed
6.
go back to reference van Krimpen C, Elferink A, Broodman CA, Hop WC, Pronk A, Menke M. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast. 2004;13:329–33.CrossRefPubMed van Krimpen C, Elferink A, Broodman CA, Hop WC, Pronk A, Menke M. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast. 2004;13:329–33.CrossRefPubMed
7.
go back to reference Adams RW, Dyson P, Barthelmes L. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast? Breast. 2014;23:120–7.CrossRefPubMed Adams RW, Dyson P, Barthelmes L. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast? Breast. 2014;23:120–7.CrossRefPubMed
8.
go back to reference Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol. 2005;58:775–8.CrossRefPubMedPubMedCentral Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol. 2005;58:775–8.CrossRefPubMedPubMedCentral
9.
go back to reference Ge QD, Lv N, Cao Y, Wang X, Tang J, Xie ZM, et al. A case report of primary small cell carcinoma of the breast and review of the literature. Chin J Cancer. 2012;31:354–8.PubMedPubMedCentral Ge QD, Lv N, Cao Y, Wang X, Tang J, Xie ZM, et al. A case report of primary small cell carcinoma of the breast and review of the literature. Chin J Cancer. 2012;31:354–8.PubMedPubMedCentral
10.
go back to reference Jiang J, Wang G, Lv L, Liu C, Liang X, Zhao H. Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature. Onco Targets Ther. 2014;7:663–6.CrossRefPubMedPubMedCentral Jiang J, Wang G, Lv L, Liu C, Liang X, Zhao H. Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature. Onco Targets Ther. 2014;7:663–6.CrossRefPubMedPubMedCentral
11.
go back to reference Shin SJ, DeLellis RA, Ying L, Rosen PP. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24:1231–8.CrossRefPubMed Shin SJ, DeLellis RA, Ying L, Rosen PP. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24:1231–8.CrossRefPubMed
12.
go back to reference Hare F, Giri S, Patel JK, Hahn A, Martin MG. A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus. 2015;4:138.CrossRefPubMedPubMedCentral Hare F, Giri S, Patel JK, Hahn A, Martin MG. A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus. 2015;4:138.CrossRefPubMedPubMedCentral
13.
go back to reference Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J Pathol. 1985;120:186–92.PubMedPubMedCentral Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J Pathol. 1985;120:186–92.PubMedPubMedCentral
14.
go back to reference Rovera F, Lavazza M, Rosa SL, Fachinetti A, Chiappa C, Marelli M, et al. Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature. Int J Surg. 2013;11 Suppl 1:79–83.CrossRef Rovera F, Lavazza M, Rosa SL, Fachinetti A, Chiappa C, Marelli M, et al. Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature. Int J Surg. 2013;11 Suppl 1:79–83.CrossRef
15.
go back to reference Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010;116:4463–73.CrossRefPubMed Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010;116:4463–73.CrossRefPubMed
16.
go back to reference Feki J, Fourati N, Mnif H, Khabir A, Toumi N, Khanfir A, et al. Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review. Cancer Radiother. 2015;19:308–12.CrossRefPubMed Feki J, Fourati N, Mnif H, Khabir A, Toumi N, Khanfir A, et al. Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review. Cancer Radiother. 2015;19:308–12.CrossRefPubMed
17.
go back to reference Sapino A, Papotti M, Righi L, Cassoni P, Chiusa L, Bussolati G. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol. 2001;12 Suppl 2:115–7.CrossRef Sapino A, Papotti M, Righi L, Cassoni P, Chiusa L, Bussolati G. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol. 2001;12 Suppl 2:115–7.CrossRef
18.
go back to reference Bigotti G, Coli A, Butti A, del Vecchio M, Tartaglione R, Massi G. Primary small cell neuroendocrine carcinoma of the breast. J Exp Clin Cancer Res. 2004;23:691–6.PubMed Bigotti G, Coli A, Butti A, del Vecchio M, Tartaglione R, Massi G. Primary small cell neuroendocrine carcinoma of the breast. J Exp Clin Cancer Res. 2004;23:691–6.PubMed
19.
go back to reference Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, et al. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011;42:1169–77.CrossRefPubMed Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, et al. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011;42:1169–77.CrossRefPubMed
20.
go back to reference McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein M, et al. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016;158:195–202.CrossRefPubMed McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein M, et al. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016;158:195–202.CrossRefPubMed
21.
go back to reference Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216:141–50.CrossRefPubMed Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216:141–50.CrossRefPubMed
22.
go back to reference Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A, et al. Neuroendocrine carcinoma of the breast: current evidence and future perspectives. Oncologist. 2016;21:28–32.CrossRefPubMed Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A, et al. Neuroendocrine carcinoma of the breast: current evidence and future perspectives. Oncologist. 2016;21:28–32.CrossRefPubMed
23.
go back to reference Berruti A, Saini A, Leonardo E, Cappia S, Borasio P, Dogliotti L. Management of neuroendocrine differentiated breast carcinoma. Breast. 2004;13:527–9.CrossRefPubMed Berruti A, Saini A, Leonardo E, Cappia S, Borasio P, Dogliotti L. Management of neuroendocrine differentiated breast carcinoma. Breast. 2004;13:527–9.CrossRefPubMed
24.
go back to reference Yildirim Y, Elagoz S, Koyuncu A, Aydin C, Karadayi K. Management of neuroendocrine carcinomas of the breast: A rare entity. Oncol Lett. 2011;2:887–90.PubMedPubMedCentral Yildirim Y, Elagoz S, Koyuncu A, Aydin C, Karadayi K. Management of neuroendocrine carcinomas of the breast: A rare entity. Oncol Lett. 2011;2:887–90.PubMedPubMedCentral
25.
go back to reference Watrowski R, Jager C, Mattern D, Horst C. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications. Anticancer Res. 2012;32:5079–82.PubMed Watrowski R, Jager C, Mattern D, Horst C. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications. Anticancer Res. 2012;32:5079–82.PubMed
26.
go back to reference Latif N, Rosa M, Samian L, Rana F. An unusual case of primary small cell neuroendocrine carcinoma of the breast. Breast J. 2010;16:647–51.CrossRefPubMed Latif N, Rosa M, Samian L, Rana F. An unusual case of primary small cell neuroendocrine carcinoma of the breast. Breast J. 2010;16:647–51.CrossRefPubMed
Metadata
Title
Primary small cell carcinoma of the breast: a case report
Authors
Iman Abou Dalle
Jaber Abbas
Fouad Boulos
Ziad Salem
Hazem I. Assi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1467-0

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue